Yating Zou

ORCID: 0009-0000-2506-8907
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cervical Cancer and HPV Research
  • Global Cancer Incidence and Screening
  • HIV/AIDS Research and Interventions
  • Adolescent Sexual and Reproductive Health
  • HIV, Drug Use, Sexual Risk
  • Radiomics and Machine Learning in Medical Imaging
  • Medical Imaging Techniques and Applications
  • Head and Neck Cancer Studies
  • HIV/AIDS Impact and Responses
  • Family Support in Illness

University of North Carolina at Chapel Hill
2019-2025

Innovative strategies are urgently needed to meet the World Health Organization’s 2030 target of treating 90% women with precancerous cervical lesions, especially in countries most affected by cancer. We assessed acceptability self-administered intravaginal therapies for precancer undergoing cancer screening and treatment Kenya. conducted a cross-sectional study among aged 18 65 years or between January October 2023 Kisumu County, Participants completed questionnaire about their perceptions...

10.1525/agh.2025.2329438 article EN cc-by Advances in Global Health 2025-01-01

Abstract Purpose Innovative strategies are urgently needed to meet the World Health Organization’s 2030 target of treating 90% women with precancerous cervical lesions, especially in countries most affected by cancer. We assessed acceptability self-administered intravaginal therapies for precancer undergoing cancer screening and treatment Kenya. Methods conducted a cross-sectional study among aged 18 65 years or between January October 2023 Kisumu County, Participants completed questionnaire...

10.1101/2024.03.05.24303779 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2024-03-06

Background: Cervical cancer continues to be a major health issue in low-and middleincome countries (LMICs).Despite increasing access screening, precancer treatment remains significant challenge LMICs, highlighting need for innovative, accessible and resource-appropriate approaches, including self-administered therapies. Methods:A cross-sectional mixed-methods study was conducted among men aged 25-65 with current female partner Kisumu County, Kenya.Participants were sequentially recruited...

10.3332/ecancer.2024.1719 article EN cc-by ecancermedicalscience 2024-06-24

Women in Africa disproportionately acquire human immunodeficiency virus type 1 (HIV-1). Understanding which women are most likely to HIV-1 can guide focused prevention with preexposure prophylaxis (PrEP). Our objective was identify at the highest risk of and estimate PrEP efficiency different sensitivity levels. Nationally representative data were collected from 2015 through 2019 15 population-based household surveys. This analysis included aged 15-49 who tested seronegative or had recent...

10.1093/cid/ciae211 article EN cc-by-nc-nd Clinical Infectious Diseases 2024-04-22

Cervical cancer continues to be a major health issue in low- and middle-income countries (LMICs). Despite increasing access screening, precancer treatment remains significant challenge LMICs, highlighting need for innovative, accessible, resource-appropriate approaches, including self-administered therapies.

10.1101/2024.02.06.24302397 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2024-02-07

Background: Women in Africa disproportionately acquire HIV-1. Understanding which women are most likely to HIV-1 can guide focused prevention, including pre-exposure prophylaxis (PrEP). Machine learning was used develop a risk assessment tool identifying and estimate infections averted with PrEP delivery.Methods: Nationally representative data were collected from 2015-2019 15 population-based household surveys. This analysis included aged 15-49 years who tested sero-negative or had recent...

10.2139/ssrn.4594389 preprint EN 2023-01-01
Coming Soon ...